Abbott Book Value Per Share from 2010 to 2025

ABT Stock

USD 130.35 3.74 2.95%

Abbott Laboratories Book Value Per Share yearly trend continues to be comparatively stable with very little volatility. Book Value Per Share is likely to outpace its year average in 2025. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Abbott Laboratories according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

27.66128981

Current Value

29.04

Quarterly Volatility

6.26491387

Credit Downgrade

Yuan Drop

Covid

Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 B, Interest Expense of 531 M or Selling General Administrative of 6.4 B, as well as many indicators such as Price To Sales Ratio of 4.9, Dividend Yield of 0.0186 or PTB Ratio of 2.63. Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.

Check out the analysis of Abbott Laboratories Correlation against competitors.

For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Latest Abbott Laboratories' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Abbott Laboratories over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Abbott Laboratories' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abbott Laboratories' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 27.52 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Abbott Book Value Per Share Regression Statistics

	Arithmetic Mean	17.81
	Geometric Mean	15.41
	Coefficient Of Variation	35.18
	Mean Deviation	4.03
	Median	17.70
	Standard Deviation	6.26
	Sample Variance	39.25
	Range	28.0349
	R-Value	0.84
	Mean Square Error	12.37
	R-Squared	0.71
	Significance	0.000046
	Slope	1.11
	Total Sum of Squares	588.74

Abbott Book Value Per Share History

	2025	29.04
	2024	27.66
	2023	22.39
	2022	21.05
	2021	20.3
	2020	18.61
	2019	17.7

Other Fundumenentals of Abbott Laboratories

Tangible Book Value Per Share

Abbott Laboratories Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Current Deferred Revenue	Short Term Investments	Common Stock	Intangible Assets	Long Term Debt	Treasury Stock	Property Plant Equipment	Good Will	Net Tangible Assets	Long Term Debt Total	Long Term Investments	Accumulated Depreciation	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.92	0.65	0.82	0.86	0.79	0.6	-0.13	0.84	-0.68	-0.13	-0.01	0.61	0.7	-0.69	0.84	0.84	-0.09	0.58	-0.22	-0.53	0.37	-0.69	-0.27	-0.36	0.58
Total Stockholder Equity	0.92		0.4	0.95	0.88	0.51	0.42	-0.05	0.88	-0.73	-0.14	-0.12	0.38	0.4	-0.69	0.81	0.73	0.17	0.34	-0.21	-0.52	0.43	-0.67	-0.14	-0.34	0.79
Net Debt	0.65	0.4		0.17	0.36	0.8	0.25	-0.42	0.46	-0.28	-0.19	0.01	0.97	0.8	-0.37	0.53	0.83	-0.71	0.7	-0.27	-0.2	-0.03	-0.72	-0.57	-0.58	-0.04
Retained Earnings	0.82	0.95	0.17		0.82	0.36	0.4	0.07	0.79	-0.73	-0.17	-0.17	0.14	0.27	-0.71	0.7	0.54	0.38	0.21	-0.01	-0.43	0.5	-0.51	0.02	-0.21	0.83
Net Receivables	0.86	0.88	0.36	0.82		0.53	0.51	0.06	0.73	-0.42	0.05	0.22	0.29	0.37	-0.34	0.81	0.62	0.12	0.33	-0.33	-0.68	0.27	-0.46	0.03	-0.19	0.7
Total Liab	0.79	0.51	0.8	0.36	0.53		0.75	-0.21	0.55	-0.43	-0.06	0.12	0.74	0.88	-0.53	0.71	0.81	-0.41	0.69	-0.2	-0.36	0.21	-0.49	-0.41	-0.29	0.0
Total Current Assets	0.6	0.42	0.25	0.4	0.51	0.75		0.19	0.32	-0.37	0.34	0.16	0.15	0.55	-0.38	0.55	0.39	0.1	0.34	-0.15	-0.35	0.3	0.04	0.03	0.17	0.02
Short Term Debt	-0.13	-0.05	-0.42	0.07	0.06	-0.21	0.19		-0.31	-0.06	0.43	0.33	-0.39	-0.5	0.08	-0.22	-0.37	0.4	-0.71	-0.06	0.21	0.02	0.56	0.41	0.4	-0.08
Accounts Payable	0.84	0.88	0.46	0.79	0.73	0.55	0.32	-0.31		-0.63	-0.36	-0.16	0.45	0.45	-0.66	0.88	0.84	0.1	0.43	-0.24	-0.7	0.49	-0.81	-0.46	-0.46	0.74
Current Deferred Revenue	-0.68	-0.73	-0.28	-0.73	-0.42	-0.43	-0.37	-0.06	-0.63		0.2	0.24	-0.35	-0.33	0.86	-0.48	-0.53	-0.21	-0.14	0.03	0.0	-0.42	0.54	0.31	0.34	-0.45
Short Term Investments	-0.13	-0.14	-0.19	-0.17	0.05	-0.06	0.34	0.43	-0.36	0.2		0.07	-0.23	-0.22	0.35	-0.16	-0.27	0.15	-0.35	-0.27	0.04	-0.29	0.48	0.28	0.32	-0.28
Common Stock	-0.01	-0.12	0.01	-0.17	0.22	0.12	0.16	0.33	-0.16	0.24	0.07		0.0	-0.05	0.43	0.05	-0.05	-0.15	-0.11	-0.18	-0.18	-0.16	0.28	0.16	0.18	-0.17
Intangible Assets	0.61	0.38	0.97	0.14	0.29	0.74	0.15	-0.39	0.45	-0.35	-0.23	0.0		0.75	-0.41	0.44	0.79	-0.75	0.64	-0.25	-0.11	-0.05	-0.74	-0.61	-0.56	-0.03
Long Term Debt	0.7	0.4	0.8	0.27	0.37	0.88	0.55	-0.5	0.45	-0.33	-0.22	-0.05	0.75		-0.48	0.49	0.67	-0.53	0.92	-0.01	-0.21	0.17	-0.53	-0.35	-0.29	0.03
Treasury Stock	-0.69	-0.69	-0.37	-0.71	-0.34	-0.53	-0.38	0.08	-0.66	0.86	0.35	0.43	-0.41	-0.48		-0.49	-0.6	-0.08	-0.3	-0.26	0.03	-0.44	0.57	0.36	0.33	-0.4
Property Plant Equipment	0.84	0.81	0.53	0.7	0.81	0.71	0.55	-0.22	0.88	-0.48	-0.16	0.05	0.44	0.49	-0.49		0.88	0.03	0.45	-0.37	-0.75	0.41	-0.64	-0.31	-0.36	0.52
Good Will	0.84	0.73	0.83	0.54	0.62	0.81	0.39	-0.37	0.84	-0.53	-0.27	-0.05	0.79	0.67	-0.6	0.88		-0.32	0.58	-0.35	-0.54	0.28	-0.83	-0.58	-0.56	0.34
Net Tangible Assets	-0.09	0.17	-0.71	0.38	0.12	-0.41	0.1	0.4	0.1	-0.21	0.15	-0.15	-0.75	-0.53	-0.08	0.03	-0.32		-0.51	0.14	-0.18	0.44	0.28	0.28	0.21	0.45
Long Term Debt Total	0.58	0.34	0.7	0.21	0.33	0.69	0.34	-0.71	0.43	-0.14	-0.35	-0.11	0.64	0.92	-0.3	0.45	0.58	-0.51		-0.01	-0.3	0.19	-0.55	-0.25	-0.27	0.13
Long Term Investments	-0.22	-0.21	-0.27	-0.01	-0.33	-0.2	-0.15	-0.06	-0.24	0.03	-0.27	-0.18	-0.25	-0.01	-0.26	-0.37	-0.35	0.14	-0.01		0.44	0.05	0.2	0.15	0.13	-0.09
Accumulated Depreciation	-0.53	-0.52	-0.2	-0.43	-0.68	-0.36	-0.35	0.21	-0.7	0.0	0.04	-0.18	-0.11	-0.21	0.03	-0.75	-0.54	-0.18	-0.3	0.44		-0.33	0.37	0.22	0.15	-0.57
Short Long Term Debt	0.37	0.43	-0.03	0.5	0.27	0.21	0.3	0.02	0.49	-0.42	-0.29	-0.16	-0.05	0.17	-0.44	0.41	0.28	0.44	0.19	0.05	-0.33		-0.28	-0.07	-0.17	0.45
Cash And Equivalents	-0.69	-0.67	-0.72	-0.51	-0.46	-0.49	0.04	0.56	-0.81	0.54	0.48	0.28	-0.74	-0.53	0.57	-0.64	-0.83	0.28	-0.55	0.2	0.37	-0.28		0.67	0.8	-0.49
Net Invested Capital	-0.27	-0.14	-0.57	0.02	0.03	-0.41	0.03	0.41	-0.46	0.31	0.28	0.16	-0.61	-0.35	0.36	-0.31	-0.58	0.28	-0.25	0.15	0.22	-0.07	0.67		0.78	0.05
Net Working Capital	-0.36	-0.34	-0.58	-0.21	-0.19	-0.29	0.17	0.4	-0.46	0.34	0.32	0.18	-0.56	-0.29	0.33	-0.36	-0.56	0.21	-0.27	0.13	0.15	-0.17	0.8	0.78		-0.16
Capital Stock	0.58	0.79	-0.04	0.83	0.7	0.0	0.02	-0.08	0.74	-0.45	-0.28	-0.17	-0.03	0.03	-0.4	0.52	0.34	0.45	0.13	-0.09	-0.57	0.45	-0.49	0.05	-0.16

Click cells to compare fundamentals

About Abbott Laboratories Financial Statements

Abbott Laboratories shareholders use historical fundamental indicators, such as Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may analyze each financial statement separately, they are all interrelated. The changes in Abbott Laboratories' assets and liabilities, for example, are also reflected in the revenues and expenses on on Abbott Laboratories' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Book Value Per Share	27.66	29.04
Tangible Book Value Per Share	10.48	11.00

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC